Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-24-000303
Filing Date
2024-03-20
Accepted
2024-03-20 13:00:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 biofrontera13g.htm SC 13G 28890
  Complete submission text file 0000935836-24-000303.txt   30203
Mailing Address 467 CENTRAL PARK WEST NY NY 10025
Business Address
LYTTON LAURENCE W (Filed by) CIK: 0001105806 (see all company filings)

Type: SC 13G

Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Subject) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93395 | Film No.: 24767197
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)